Selected article for: "respiratory failure and treatment strategy"

Author: Tutusaus, Anna; Marí, Montserrat; Ortiz-Pérez, José T.; Nicolaes, Gerry A. F.; Morales, Albert; García de Frutos, Pablo
Title: Role of Vitamin K-Dependent Factors Protein S and GAS6 and TAM Receptors in SARS-CoV-2 Infection and COVID-19-Associated Immunothrombosis
  • Cord-id: 1cpkl290
  • Document date: 2020_9_28
  • ID: 1cpkl290
    Snippet: The vitamin K-dependent factors protein S (PROS1) and growth-arrest-specific gene 6 (GAS6) and their tyrosine kinase receptors TYRO3, AXL, and MERTK, the TAM subfamily of receptor tyrosine kinases (RTK), are key regulators of inflammation and vascular response to damage. TAM signaling, which has largely studied in the immune system and in cancer, has been involved in coagulation-related pathologies. Because of these established biological functions, the GAS6-PROS1/TAM system is postulated to pla
    Document: The vitamin K-dependent factors protein S (PROS1) and growth-arrest-specific gene 6 (GAS6) and their tyrosine kinase receptors TYRO3, AXL, and MERTK, the TAM subfamily of receptor tyrosine kinases (RTK), are key regulators of inflammation and vascular response to damage. TAM signaling, which has largely studied in the immune system and in cancer, has been involved in coagulation-related pathologies. Because of these established biological functions, the GAS6-PROS1/TAM system is postulated to play an important role in SARS-CoV-2 infection and progression complications. The participation of the TAM system in vascular function and pathology has been previously reported. However, in the context of COVID-19, the role of TAMs could provide new clues in virus-host interplay with important consequences in the way that we understand this pathology. From the viral mimicry used by SARS-CoV-2 to infect cells, to the immunothrombosis that is associated with respiratory failure in COVID-19 patients, TAM signaling seems to be involved at different stages of the disease. TAM targeting is becoming an interesting biomedical strategy, which is useful for COVID-19 treatment now, but also for other viral and inflammatory diseases in the future.

    Search related documents:
    Co phrase search for related documents
    • activator signal transducer and acute inflammation: 1, 2, 3
    • activator signal transducer and acute lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • activator signal transducer and acute myeloid leukemia: 1, 2
    • activator signal transducer and acute pneumonia: 1, 2
    • activator transducer and acute inflammation: 1, 2, 3
    • activator transducer and acute lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • activator transducer and acute myeloid leukemia: 1, 2
    • activator transducer and acute pneumonia: 1, 2